started · updated
Eli Lilly raises revenue guidance following strong weight loss drug sales
Eli Lilly has increased its full-year 2026 revenue guidance to a range between $91 billion and $92 billion, up from a previous estimate of $85 billion to $87 billion. This adjustment follows a third-quarter earnings report that surpassed analyst expectations, driven largely by the company’s GLP-1 agonist portfolio.
Diabetes treatment Mounjaro generated $10.72 billion in worldwide revenue for the quarter, representing 65% growth. Zepbound, used for obesity, posted $5.35 billion in quarterly revenue, a 49% increase year-over-year. While the newly launched oral obesity pill Foundayo reported $184 million in sales, it fell short of the approximately $229 million expected by analysts.
CEO Dave Ricks noted significant potential for market expansion, stating that current obesity treatment access affects only 3% to 10% of eligible patients in the United States. The company currently holds a 63% share of the U.S. obesity and diabetes drug market.
Entities
Berkshire Hathaway · Dave Ricks · David Ricks · Eli Lilly · Eli Lilly and Company · Foundayo · Mounjaro · Samsung Electronics · Zepbound
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] Mounjaro generated $10.72 billion in worldwide revenue for the third quarter. rocketnews.com · www.marketbeat.com
- [○ 1 SOURCE] Zepbound posted $5.35 billion in quarterly revenue. rocketnews.com
- [● 2 SOURCES] Eli Lilly raised its 2026 revenue guidance to between $91 billion and $92 billion. rocketnews.com · www.marketbeat.com
- [○ 1 SOURCE] Mounjaro sales outside the U.S. increased by 93%. rocketnews.com
- [● 3 SOURCES] Eli Lilly's revenue increased by 39% year-over-year in the third quarter. www.thebionews.net · www.fool.com · www.marketbeat.com
- [○ 1 SOURCE] Eli Lilly holds 63% of the U.S. obesity and diabetes drug market. rocketnews.com
- [○ 1 SOURCE] CEO Dave Ricks stated that obesity treatment access affects only 3% to 10% of eligible U.S. patients. rocketnews.com
- [○ 1 SOURCE] Foundayo generated $184 million in third-quarter sales. rocketnews.com